Putnam Investments LLC United Therapeutics Corp Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $7.81 Million - $10.6 Million
37,900 New
37,900 $10.5 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $14.8 Million - $19 Million
-88,875 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $6.53 Million - $8.12 Million
38,316 Added 75.78%
88,875 $15.9 Million
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $7.78 Million - $8.84 Million
50,559 New
50,559 $8.46 Million

Others Institutions Holding UTHR

# of Institutions
692
Shares Held
60.6M
Call Options Held
194K
Put Options Held
298K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email